🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks AK Eisfeld for your visit! Enjoyed reconnecting again!

Another exciting milestone. Bofei Wang and Patrick Reville, MD, MPH beautifully describe IFNg impact in AML’s venetoclax resistance and immune evasion. Now published in Nature Communications. MD Anderson Cancer Center . More to come from our lab! nature.com/articles/s4146…

Another story from the lab fresh in the press! Studying B cells and their repertoires; the unsung players in AML. Kudos to the team work and collaborative efforts. Patrick Reville, MD, MPH DP Hao Nance and Gopi Mohan MD, PhD. MD Anderson Cancer Center

What are the latest advances in single cell profiling? Our Dr. Abbas Hussein outlined five applications of this technology. Hussein Abbas AACR #AACR24 #EndCancer

Great time at AACR Annual meeting. Plenary talks by Aviv Regev and Jakob Kather yesterday had deep insights into application of AI/DL/LLM in patient care.

Poster sessions at AACR are great opportunities to identify potential collaborators and have direct FaceTime with researchers to exchange ideas and contacts. Something I appreciate more and more with every annual meeting.

When in Universität Bern you bike your way through the hospital tunnels. A fun experience. Great hospitality by Prof Adrian Ochsenbein and his colleagues. Thanks for hosting me and discussing collaborations

Very Proud of Bofei Wang. Joined as a postdoc in Jan 2022. Now with numerous papers, contributions to grants, and now awarded the Endowed Fellowship for Research Excellence in Leukemia Research at MDA. Driven, motivated, hardworking #RightAttitude. Congrats. MD Anderson Cancer Center

Glad to see the work from the lab being featured. Bofei Wang Patrick Reville, MD, MPH spearheaded this effort. We hope furthering this work can translate into better treatments for AML patients. More to come From Hussein Abbas . MD Anderson Cancer Center nature.com/articles/d4247…

DOD grant on TP53 AML was awarded!! Back to my graduate school roots. Important to realize that i had 7 unfunded DOD applications over past 3 years that preceded this successful one. Learnt a lot from reviewers’ comments. #KeepItReal #LeukemiaResearch MD Anderson Cancer Center

Stem cell-like states confer poor outcomes in blood cancer—but what mechanisms drive this and how can they be therapeutically targeted? In our new preprint, we show how a single TF represses one enhancer to maintain a subset of high-risk leukemias: 🧵👇 biorxiv.org/content/10.110…

Featured on the new journal cover: Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy brnw.ch/21wQbfm Hussein Abbas Naval Daver, M.D. Patrick Reville, MD, MPH

Over the past year, I've grown special interest in caring for patients with #SystemicMastocytosis and transformed my clinic to almost exclusively seeing SM patients. Research focus also transforming. Common theme is that these patients spend years frustrated before they are

🙂 Very Happy to share this comprehensive review on AML, from an MD Anderson Cancer Center perspective, discussing all that is new and exciting in the field 🩸 Hagop Kantarjian,MD ➡️ Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges ACS

➡️ Excited to share the phase 1b/2 clin trial of Aza-Ven-Magro in ND high-risk & R/R AML from MD Anderson Cancer Center led by Naval Daver, M.D., just out in Clinical Cancer Research ✅ Interesting correlative analysis by Hussein Abbas interrogating mech of Magro resistance in TP53-mut AML ✅Despite

New paper, we used spectral flow cytometry panels to characterize AML and T cells. Hussein Abbas Comprehensive Profiling of AML and T Cell States Across Disease Stages in Acute Myeloid Leukemia Using Spectral Flow Cytometry ashpublications.org/bloodict/artic…

Huge props to Chris Ly, Ivo Veletic, MD and the whole team after a ton of trial-and-error, to perform high-throughput spatial CyTof and Lunaphore on bone marrow samples in AML. Just the beginning of this proof-of-concept work. nature.com/articles/s4169…